Bio Green Med Solution Q3 net loss narrows 55% to $449,000
BGMS•Bio Green Med Solution’s third-quarter net loss narrowed 55% year over year to $449,000, while revenue rose to $454,000. The company had $3.45 million in cash at September 30, 2026, and expects resources to fund planned spending into the second quarter of 2027.
1. Quarterly results
Bio Green Med Solution reported a third-quarter net loss of $449,000, down 55% year over year. Revenue rose to $454,000, and general and administrative expenses fell 37% to $635,000.
2. Cash and proposed deal
Cash totaled $3.45 million at September 30, 2026. Management expects current resources to fund planned expenditure into the second quarter of 2027, and the company plans to seek shareholder approval in November 2026 for a proposed business combination with Future NRG.
